Fasudil inhibits the activation of microglia and astrocytes of transgenic Alzheimer's disease mice via the downregulation of TLR4/Myd88/NF-κB pathway
Min-Fang Guo,Hui-Yu Zhang,Yan-Hua Li,Qing-Fang Gu,Wen-Yue Wei,Yu-Yin Wang,Xiao-Juan Zhang,Xiao-Qin Liu,Li-Juan Song,Zhi Chai,Jie-Zhong Yu,Cun-Gen Ma,Min-fang Guo,Hui-yu Zhang,Yan-hua Li,Qing-fang Gu,Wen-yue Wei,Yu-yin Wang,Xiao-juan Zhang,Xiao-qin Liu,Li-juan Song,Jie-zhong Yu,Cun-gen Ma
DOI: https://doi.org/10.1016/j.jneuroim.2020.577284
IF: 3.221
2020-09-01
Journal of Neuroimmunology
Abstract:<p>Emerging evidence suggests an association of Alzheimer's Disease (AD) with microglial and astrocytic dysregulation. Recent studies have proposed thatactivated microglia can transform astrocytes to a neurotoxic A1 phenotype, which has been shown to be involved in the promotion of neuronal damage in severalneurodegenerative diseases, including AD. In the present study, we observed anobvious microglial activation and A1-specific astrocyte response in the brain tissue of APP/PS1 Tg mice. Fasudil treatment improved the cognitive deficits of APP/PS1 Tg mice, inhibited microglial activation and promoted their transformation to ananti-inflammatory phenotype, and further shiftedastrocytes from an A1 to an A2phenotype. Our experiments suggest Fasudil exerted these functions by inhibing the expression of TLR4, MyD88, and NF-κB, which are key mediators of inflammation.</p><p>Using in vitro experiments, we further validated in vivofindings. Our cell experimentsindicated that Fasudil induces a shift of inflammatory microglia towards ananti-inflammatory phenotype. LPS-induced microglia-conditioned medium promotesA1 astrocytic polarization, but Fasudil treatment resulted in a direct transformation ofA1 astrocytes to A2. To summarize, our resultsshow that Fasudil inhibits theneurotoxic activation of microglia and shifts astrocytes towards a neuroprotectiveA2 phenotype, representing a promising candidate for AD treatment.</p>
immunology,neurosciences